Evidence map›Paper›PMID 39555749›Full record

ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2025

Cross-population validation of the PreMO risk indicator for predicting myopia onset in children.

Jane M Fulton, Tsz Wing Leung, Sara J McCullough, Kathryn J Saunders, Nicola S Logan, Carly S Y Lam, Lesley Doyle

Abstract readValidation StudyMulticenter Study
In one paragraph

Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Identifying and Managing Pre-Myopia: A Narrative Review.Clinical ophthalmology (Auckland, N.Z.) · 2026
    Review
  4. Factors predicting myopia incidence in China and Europe.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
  5. IMI-2025 Digest.Investigative ophthalmology & visual science · 2025
    Article
  6. IMI-Interventions for Controlling Myopia Onset and Progression 2025.Investigative ophthalmology & visual science · 2025
    Review
  7. Article
  8. Article
  9. Cross-population validation of the PreMO risk indicator for predicting myopia onset in children.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jane M FultonCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.ORCID 0000-0002-1003-3450
Tsz Wing LeungResearch Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong.ORCID 0000-0001-9588-2891
Sara J McCulloughCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.ORCID 0000-0002-4438-1154
Kathryn J SaundersCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.ORCID 0000-0002-9289-5731
Nicola S LoganSchool of Optometry, Aston University, Birmingham, UK.ORCID 0000-0002-0538-9516
Carly S Y LamResearch Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong.ORCID 0000-0002-6808-5018
Lesley DoyleCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.ORCID 0000-0001-9549-7192

Funding

College of OptometristsDepartment for the Economy PhD StudentshipHK PolyU grant ZECHHong Kong Special Administrative Region GovernmentInnoHK InitiativeInnovation and Technology Fund for Better Living ITB/FBL/8037/21/P
6 · The paper itself

Abstract

purposeThe Predicting Myopia Onset and progression (PreMO) risk indicator, developed using data generated from white children in the UK, incorporates age, spherical equivalent refraction (SER), axial length (AL) and parental myopia to stratify the likelihood of developing myopia. This study evaluated the PreMO's predictive accuracy using prospective datasets from independent samples of children in Hong Kong (HK) and an ethnically diverse cohort of children in the United Kingdom.

methodsNon-myopic children (SER > -0.50 D) aged 6-8 and 9-10 years were scored using the PreMO risk indicator framework, integrating baseline cycloplegic SER, AL and parental myopia data. Scores were assigned risk categories as follows: 0 = no risk, 1-3 = low risk, 4-6 = moderate risk and 7-9 = high risk. SER at ≥15 years of age was used to define refractive outcomes as 'myopic' or 'not myopic'. PreMO's predictive accuracy was analysed via Receiver Operator Characteristic curves, with Youden's J-Index identifying the optimal risk score threshold. Sensitivity, specificity and area under the curve were determined and compared with those of singular predictors, that is, SER < +0.75 D and AL ≥ 23.07 mm at 6-8 years.

resultsIn the cohort of children aged 6-8 years, a PreMO risk score ≥ 4 exhibited high sensitivity in predicting myopia onset in UK (0.97) and HK (0.94) children, with high specificity in UK (0.96) and moderate specificity in HK (0.64) children. In UK children aged 6-8 years, the PreMO outperformed singular predictors such as SER and AL. Among HK children aged 9-10 years, the PreMO score maintained high sensitivity (0.90) and moderate specificity (0.72).

conclusionsA PreMO risk score ≥ 4 is a strong predictive indicator for future myopia onset, particularly in UK children. Despite high sensitivity in both UK and HK cohorts, specificity varied, indicating the need for contextual application of the tool, particularly in pre-myopic Asian children.

Indexed as

Disease ProgressionMyopiaRefraction, OcularChildFemaleHong KongHumansMaleProspective StudiesRisk AssessmentRisk FactorsROC CurveUnited Kingdommyopiamyopia onsetmyopia predictionPreMO risk indicatorpre‐myopiarisk of myopia

Identifiers

PMID39555749
PMCPMC11629840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.